| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STTK | Common Stock | Options Exercise | $16,322 | +4,650 | +5.9% | $3.51 | 83,982 | 06 Mar 2024 | Direct | |
| transaction | STTK | Common Stock | Sale | $48,964 | -4,650 | -5.5% | $10.53 | 79,332 | 06 Mar 2024 | Direct | F1 |
| transaction | STTK | Common Stock | Options Exercise | $23,059 | +6,459 | +8.1% | $3.57 | 85,791 | 06 Mar 2024 | Direct | |
| transaction | STTK | Common Stock | Sale | $68,013 | -6,459 | -7.5% | $10.53 | 79,332 | 06 Mar 2024 | Direct | F1 |
| transaction | STTK | Common Stock | Sale | $51,544 | -4,895 | -6.2% | $10.53 | 74,437 | 06 Mar 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | STTK | Stock Option (Right to Buy) | Options Exercise | $0 | -4,650 | -33% | $0.000000 | 9,300 | 06 Mar 2024 | Common Stock | 4,650 | $3.51 | Direct | F2 |
| transaction | STTK | Stock Option (Right to Buy) | Options Exercise | $0 | -6,459 | -27% | $0.000000 | 17,391 | 06 Mar 2024 | Common Stock | 6,459 | $3.57 | Direct | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023. |
| F2 | The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024. |
| F3 | The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027. |
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer